Better IVF/ICSI success rates with metformin use in women with polycystic ovary

• Autores: Vargas Tominaga, Luis, Vargas Lechuga, Albert, Pella, Ricardo, Sierra, José, Núñez, Lizardo, Cuadros, Rina
• Formato: artículo
• Fecha de Publicación: 2015
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español
• OAI Identifier: oai:ojs.pkp.sfu.ca:article/213
• Enlace del recurso: http://51.222.106.123/index.php/RPGO/article/view/213
• Nivel de acceso: acceso abierto

Objectives: To determine metformin influence in in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) success rates in women with polycystic ovaries (PCO). Design: Retrospective study. Setting: Fertility and Gynecology Southern Center, Cusco, Peru. Participants: Women with polycystic ovaries  associated infertility. Methods: We compared IVF/ICSI success rates in 7 women with diagnosis of PCO who  used metformin and 9 women with PCO who did not use metformin. Main outcomes measures: Pregnancy. Results:  In PCO women using metformin implantation rate was 35%, biochemical pregnancy rate 71,4%, and clinical pregnancy rate 57,1%. In PCO women not using metformin, success rates were respectively 0%, 11,1%, and 0%. Conclusions: Metformin use improved IVF/ICSI success rates in PCO women.